- Home
- PULM vs ZDAI Comparison
PULM vs ZDAI Comparison
Compare PULM & ZDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- ZDAI
- Stock Information
- Founded
- PULM 2003
- ZDAI 2022
- Country
- PULM United States
- ZDAI Hong Kong
- Employees
- PULM N/A
- ZDAI N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- ZDAI General Bldg Contractors - Nonresidential Bldgs
- Sector
- PULM Health Care
- ZDAI Consumer Discretionary
- Exchange
- PULM Nasdaq
- ZDAI Nasdaq
- Market Cap
- PULM 18.3M
- ZDAI 15.6M
- IPO Year
- PULM N/A
- ZDAI 2024
- Fundamental
- Price
- PULM N/A
- ZDAI N/A
- Analyst Decision
- PULM
- ZDAI
- Analyst Count
- PULM 0
- ZDAI 0
- Target Price
- PULM N/A
- ZDAI N/A
- AVG Volume (30 Days)
- PULM 17.8K
- ZDAI 5.5M
- Earning Date
- PULM 11-07-2025
- ZDAI 10-21-2025
- Dividend Yield
- PULM N/A
- ZDAI N/A
- EPS Growth
- PULM N/A
- ZDAI N/A
- EPS
- PULM N/A
- ZDAI N/A
- Revenue
- PULM $369,000.00
- ZDAI $19,275,673.00
- Revenue This Year
- PULM N/A
- ZDAI N/A
- Revenue Next Year
- PULM $134.88
- ZDAI N/A
- P/E Ratio
- PULM N/A
- ZDAI N/A
- Revenue Growth
- PULM N/A
- ZDAI 43.16
- 52 Week Low
- PULM $1.96
- ZDAI $0.37
- 52 Week High
- PULM $10.40
- ZDAI $107.36
- Technical
- Relative Strength Index (RSI)
- PULM 47.11
- ZDAI 53.83
- Support Level
- PULM $4.45
- ZDAI $0.62
- Resistance Level
- PULM $5.50
- ZDAI $0.66
- Average True Range (ATR)
- PULM 0.26
- ZDAI 0.05
- MACD
- PULM 0.02
- ZDAI -0.00
- Stochastic Oscillator
- PULM 38.53
- ZDAI 21.30
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About ZDAI Primega Group Holdings Limited Ordinary Shares
Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.